ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 977,95
-0,01%
Dow Jones
38 111,48
-0,86%
DAX
18 468,88
-0,24%
Brent Oil
81,765
-0,23%
Bitcoin
68 152,92
-0,30%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Kitov Pharma Ltd (KTOV)

  7. Kitov Pharma Ltd (KTOV) Actualités

KTOV

Kitov Pharma (KTOV)

Kitov Pharma Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:KTOV
DateHeureSourceTitreSymboleSociété
20/06/202314h01Edgar (US Regulatory)Amended Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k/a)NASDAQ:KTOVKitov Pharma Ltd
15/06/202322h01Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:KTOVKitov Pharma Ltd
05/04/202323h22Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:KTOVKitov Pharma Ltd
23/03/202314h23Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3)NASDAQ:KTOVKitov Pharma Ltd
03/03/202313h58Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:KTOVKitov Pharma Ltd
23/03/202222h22Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:KTOVKitov Pharma Ltd
09/04/202122h35Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:KTOVKitov Pharma Ltd
16/03/202120h23Edgar (US Regulatory)Amended Annual and Transition Report (foreign Private Issuer) (20-f/a)NASDAQ:KTOVKitov Pharma Ltd
04/02/202122h30Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:KTOVKitov Pharma Ltd
23/11/202022h17Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:KTOVKitov Pharma Ltd
08/09/202013h45Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:KTOVKitov Pharma Ltd
20/07/202012h03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:KTOVKitov Pharma Ltd
14/07/202022h04Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:KTOVKitov Pharma Ltd
30/06/202012h25Edgar (US Regulatory)Amended Report of Foreign Issuer (6-k/a)NASDAQ:KTOVKitov Pharma Ltd
18/05/202023h25Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:KTOVKitov Pharma Ltd
11/03/202014h17Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-1/a)NASDAQ:KTOVKitov Pharma Ltd
27/12/201922h10Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-1)NASDAQ:KTOVKitov Pharma Ltd
11/10/201914h54GlobeNewswire Inc.Kitov Pharma Announces Amended Marketing and Distribution Agreement with Coeptis and Provides Update on the Upcoming Launch ...NASDAQ:KTOVKitov Pharma Ltd
02/10/201914h20GlobeNewswire Inc.Kitov Pharma Appoints Eric K. Rowinsky, M.D., as Chairman of its BoardNASDAQ:KTOVKitov Pharma Ltd
09/09/201914h30GlobeNewswire Inc.Kitov Pharma Presents Newly Released Data for NT-219 in Reversing Pancreatic Cancer Drug ResistanceNASDAQ:KTOVKitov Pharma Ltd
03/09/201914h22GlobeNewswire Inc.Kitov Pharma to Present at the H.C. Wainwright 21st Annual Healthcare ConferenceNASDAQ:KTOVKitov Pharma Ltd
29/08/201914h30GlobeNewswire Inc.Kitov Pharma to Present New Data on NT-219 Targeting Cancer Drug Resistance at the AACR Pancreatic Cancer: Advances in Scienc...NASDAQ:KTOVKitov Pharma Ltd
16/08/201914h24GlobeNewswire Inc.Kitov Pharma Announces Significant Progress in Closing of FameWave Acquisition DealNASDAQ:KTOVKitov Pharma Ltd
14/08/201914h20GlobeNewswire Inc.Administrative Enforcement Agreement Finalized between Kitov Pharma and the Israeli Securities AuthorityNASDAQ:KTOVKitov Pharma Ltd
08/08/201914h20GlobeNewswire Inc.Kitov Pharma Reports First Half 2019 Financial Results and Provides Business UpdateNASDAQ:KTOVKitov Pharma Ltd
12/07/201923h11GlobeNewswire Inc.Kitov Receives Nasdaq Notification Regarding Minimum Bid RequirementsNASDAQ:KTOVKitov Pharma Ltd
27/06/201913h30GlobeNewswire Inc.Kitov Successfully Completes IND-enabling Studies to advance NT219 for the Treatment of Patients with Recurrent or Metastatic...NASDAQ:KTOVKitov Pharma Ltd
10/05/201915h20GlobeNewswire Inc.Kitov Receives Notice of Allowance for Additional U.S. Patent Covering its Commercial Product Consensi™NASDAQ:KTOVKitov Pharma Ltd
09/05/201914h30GlobeNewswire Inc.Kitov to Present Clinical Development Plan for Oncology Candidate NT-219 at the 18th MIXiii-BIOMED ConferenceNASDAQ:KTOVKitov Pharma Ltd
02/05/201922h45GlobeNewswire Inc.Kitov Announces Retirement of Founder and Executive Chairman Dr. Paul WaymackNASDAQ:KTOVKitov Pharma Ltd
 Showing the most relevant articles for your search:NASDAQ:KTOV

Dernières Valeurs Consultées

COIN
BCDTETH
NYSE
FMDE
Fidelity Covingt
LSE
49GF
Southern.h 36
NASDAQ
BSVO
EA Bridgeway Omni Small ...
COIN
BXIOTETH
bXIOT Token
BIT
SFIB3L
SG ISSUER
USOTC
MDRNF
Modern PLT Based Foods (PK)
NASDAQ
IHTT
Interactive Health
TG
ME7
MEG Energy
BOV
NFTS11
Invsto VanckETF Crypto C...
AMEX
AGZ
iShares Agency
LSE
FRGP
Ish Fr Gv Bd Gb
NASDAQ
SCPH
scPharmaceuticals
LSE
LT84
One Heritage.24
TG
2R7
Azelis Group NV
NASDAQ
ALCY
Alchemy Investments Acqu...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés